| 0 |
AMOEBIC BRAIN ABSCESS |
2 |
0.2500 |
| 1 |
SPLENIC CANDIDIASIS |
4 |
0.1739 |
| 2 |
NECROTISING FASCIITIS FUNGAL |
4 |
0.1600 |
| 3 |
LYMPHADENITIS FUNGAL |
3 |
0.1250 |
| 4 |
CEREBRAL VENTRICLE COLLAPSE |
8 |
0.1067 |
| 5 |
MENINGEAL THICKENING |
2 |
0.1053 |
| 6 |
BALAMUTHIA INFECTION |
3 |
0.1034 |
| 7 |
RETICULOENDOTHELIAL DYSFUNCTION |
1 |
0.1000 |
| 8 |
ENDOCARDITIS CANDIDA |
7 |
0.0921 |
| 9 |
DISSEMINATED CRYPTOCOCCOSIS |
66 |
0.0872 |
| 10 |
CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE |
3 |
0.0714 |
| 11 |
CRYPTOCOCCAL MENINGOENCEPHALITIS |
9 |
0.0687 |
| 12 |
PHAEOHYPHOMYCOTIC BRAIN ABSCESS |
2 |
0.0625 |
| 13 |
CRYPTOCOCCAL CUTANEOUS INFECTION |
11 |
0.0604 |
| 14 |
PERICARDITIS ADHESIVE |
2 |
0.0588 |
| 15 |
CRYPTOCOCCUS TEST POSITIVE |
3 |
0.0577 |
| 16 |
ADJUSTED CALCIUM INCREASED |
3 |
0.0566 |
| 17 |
MENINGITIS CRYPTOCOCCAL |
98 |
0.0560 |
| 18 |
DISSEMINATED TRICHOSPORONOSIS |
4 |
0.0556 |
| 19 |
ENCEPHALITIS PROTOZOAL |
3 |
0.0536 |
| 20 |
NEUTROPHIL FUNCTION DISORDER |
2 |
0.0526 |
| 21 |
TRICUSPID VALVE STENOSIS |
3 |
0.0517 |
| 22 |
CANDIDA SEROLOGY POSITIVE |
2 |
0.0488 |
| 23 |
NEUROCRYPTOCOCCOSIS |
3 |
0.0484 |
| 24 |
PERIHEPATIC ABSCESS |
4 |
0.0482 |
| 25 |
OSSEOUS CRYPTOCOCCOSIS |
1 |
0.0476 |
| 26 |
ACANTHAMOEBA INFECTION |
8 |
0.0426 |
| 27 |
INTRAOCULAR PRESSURE TEST |
10 |
0.0417 |
| 28 |
CRYPTOCOCCOSIS |
66 |
0.0405 |
| 29 |
LIVER TRANSPLANT FAILURE |
2 |
0.0364 |
| 30 |
OSTEOMYELITIS FUNGAL |
6 |
0.0359 |
| 31 |
FLUOROSIS |
3 |
0.0349 |
| 32 |
CSF GLUCOSE DECREASED |
4 |
0.0345 |
| 33 |
MENINGOENCEPHALITIS AMOEBIC |
2 |
0.0345 |
| 34 |
WHITE BLOOD CELL ANALYSIS ABNORMAL |
2 |
0.0323 |
| 35 |
OPTIC DISCS BLURRED |
2 |
0.0312 |
| 36 |
PERICARDITIS FUNGAL |
2 |
0.0303 |
| 37 |
MYOCARDITIS BACTERIAL |
1 |
0.0303 |
| 38 |
MENINGITIS CANDIDA |
2 |
0.0286 |
| 39 |
CRYPTOCOCCAL FUNGAEMIA |
4 |
0.0280 |
| 40 |
XANTHOCHROMIA |
1 |
0.0278 |
| 41 |
CSF SHUNT OPERATION |
2 |
0.0278 |
| 42 |
ACANTHAMOEBA KERATITIS |
1 |
0.0270 |
| 43 |
EYE INFECTION FUNGAL |
10 |
0.0258 |
| 44 |
PNEUMONIA CRYPTOCOCCAL |
24 |
0.0254 |
| 45 |
NEONATAL CANDIDA INFECTION |
1 |
0.0233 |
| 46 |
PITUITARY INFARCTION |
1 |
0.0233 |
| 47 |
APHAKIA |
1 |
0.0213 |
| 48 |
SPINOCEREBELLAR DISORDER |
1 |
0.0213 |
| 49 |
CEREBRAL FUNGAL INFECTION |
6 |
0.0212 |
| 50 |
MYCOTIC ENDOPHTHALMITIS |
4 |
0.0212 |
| 51 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
105 |
0.0211 |
| 52 |
FUNGAL ENDOCARDITIS |
6 |
0.0199 |
| 53 |
CSF CULTURE POSITIVE |
2 |
0.0189 |
| 54 |
PHAEOHYPHOMYCOSIS |
9 |
0.0188 |
| 55 |
INFECTION PROTOZOAL |
1 |
0.0175 |
| 56 |
AIDS ENCEPHALOPATHY |
1 |
0.0172 |
| 57 |
IMMUNE RECONSTITUTION SYNDROME |
22 |
0.0170 |
| 58 |
PREALBUMIN DECREASED |
2 |
0.0167 |
| 59 |
TONIC POSTURING |
1 |
0.0164 |
| 60 |
CEREBRAL ASPERGILLOSIS |
10 |
0.0163 |
| 61 |
REVERSIBLE SPLENIAL LESION SYNDROME |
1 |
0.0156 |
| 62 |
CENTRAL NERVOUS SYSTEM INFLAMMATION |
5 |
0.0151 |
| 63 |
PERICARDIAL FIBROSIS |
2 |
0.0144 |
| 64 |
MYOCARDIAC ABSCESS |
1 |
0.0139 |
| 65 |
HEPATOSPLENIC CANDIDIASIS |
2 |
0.0136 |
| 66 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
3 |
0.0129 |
| 67 |
DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS |
1 |
0.0128 |
| 68 |
CHRONIC GRANULOMATOUS DISEASE |
1 |
0.0122 |
| 69 |
RADIATION INTERACTION |
1 |
0.0120 |
| 70 |
ABSCESS FUNGAL |
2 |
0.0114 |
| 71 |
SCEDOSPORIUM INFECTION |
8 |
0.0113 |
| 72 |
CSF PRESSURE INCREASED |
3 |
0.0113 |
| 73 |
PROSTATIC ABSCESS |
3 |
0.0109 |
| 74 |
CSF WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0105 |
| 75 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
8 |
0.0104 |
| 76 |
ATYPICAL MYCOBACTERIUM TEST POSITIVE |
1 |
0.0103 |
| 77 |
VITH NERVE DISORDER |
1 |
0.0099 |
| 78 |
PLEURAL MESOTHELIOMA MALIGNANT |
3 |
0.0097 |
| 79 |
FUSOBACTERIUM INFECTION |
1 |
0.0085 |
| 80 |
ANTICOAGULATION DRUG LEVEL DECREASED |
1 |
0.0083 |
| 81 |
CANDIDA ENDOPHTHALMITIS |
1 |
0.0082 |
| 82 |
MUSCLE ABSCESS |
5 |
0.0080 |
| 83 |
LARYNGITIS FUNGAL |
1 |
0.0078 |
| 84 |
DISSOCIATIVE AMNESIA |
1 |
0.0077 |
| 85 |
CHEST WALL MASS |
2 |
0.0077 |
| 86 |
HISTIOCYTOSIS |
1 |
0.0075 |
| 87 |
CORYNEBACTERIUM INFECTION |
4 |
0.0075 |
| 88 |
CENTRAL NERVOUS SYSTEM NECROSIS |
2 |
0.0073 |
| 89 |
CEREBRAL CYST |
5 |
0.0073 |
| 90 |
IIIRD NERVE DISORDER |
1 |
0.0070 |
| 91 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
5 |
0.0070 |
| 92 |
CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE |
1 |
0.0068 |
| 93 |
CANDIDA SEPSIS |
6 |
0.0067 |
| 94 |
RESTRICTIVE CARDIOMYOPATHY |
2 |
0.0066 |
| 95 |
GASTROENTERITIS ROTAVIRUS |
2 |
0.0065 |
| 96 |
WOUND INFECTION PSEUDOMONAS |
2 |
0.0064 |
| 97 |
BLASTOMYCOSIS |
3 |
0.0062 |
| 98 |
CENTRAL NERVOUS SYSTEM VASCULITIS |
3 |
0.0059 |
| 99 |
ACUTE DISSEMINATED ENCEPHALOMYELITIS |
2 |
0.0058 |
| 100 |
CYTOMEGALOVIRUS ENTERITIS |
2 |
0.0056 |
| 101 |
DRUG RESISTANCE MUTATION |
1 |
0.0056 |
| 102 |
PANOPHTHALMITIS |
1 |
0.0055 |
| 103 |
PULMONARY HILUM MASS |
1 |
0.0053 |
| 104 |
PLEOCYTOSIS |
3 |
0.0052 |
| 105 |
BRAIN ABSCESS |
13 |
0.0051 |
| 106 |
PRODUCT INEFFECTIVE |
4 |
0.0051 |
| 107 |
FUNGAEMIA |
8 |
0.0051 |
| 108 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
3 |
0.0051 |
| 109 |
BONE ABSCESS |
2 |
0.0049 |
| 110 |
RENAL ABSCESS |
4 |
0.0049 |
| 111 |
HIV VIRAEMIA |
1 |
0.0048 |
| 112 |
GEOTRICHUM INFECTION |
1 |
0.0047 |
| 113 |
FRONTOTEMPORAL DEMENTIA |
2 |
0.0047 |
| 114 |
CORNEAL INFECTION |
1 |
0.0046 |
| 115 |
CENTRAL NERVOUS SYSTEM LUPUS |
1 |
0.0045 |
| 116 |
POST INFLAMMATORY PIGMENTATION CHANGE |
2 |
0.0044 |
| 117 |
SYSTEMIC CANDIDA |
11 |
0.0044 |
| 118 |
ACUTE MOTOR-SENSORY AXONAL NEUROPATHY |
1 |
0.0043 |
| 119 |
NEPHROGENIC DIABETES INSIPIDUS |
5 |
0.0043 |
| 120 |
ENCEPHALITIS |
30 |
0.0043 |
| 121 |
POST PROCEDURAL OEDEMA |
1 |
0.0043 |
| 122 |
CRANIOFACIAL DEFORMITY |
1 |
0.0043 |
| 123 |
TRAUMATIC LIVER INJURY |
1 |
0.0043 |
| 124 |
CORONARY ARTERY ANEURYSM |
1 |
0.0043 |
| 125 |
MENINGITIS FUNGAL |
1 |
0.0043 |
| 126 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
3 |
0.0043 |
| 127 |
DISSEMINATED ASPERGILLOSIS |
2 |
0.0042 |
| 128 |
CARDIAC VALVE VEGETATION |
2 |
0.0041 |
| 129 |
CEREBRAL VASOCONSTRICTION |
3 |
0.0041 |
| 130 |
TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME |
1 |
0.0040 |
| 131 |
LENTIGO |
2 |
0.0040 |
| 132 |
SEPSIS SYNDROME |
2 |
0.0040 |
| 133 |
FUNGAL PHARYNGITIS |
1 |
0.0040 |
| 134 |
HERPES ZOSTER OTICUS |
2 |
0.0039 |
| 135 |
INTRACRANIAL PRESSURE INCREASED |
22 |
0.0039 |
| 136 |
INCISION SITE ABSCESS |
1 |
0.0038 |
| 137 |
RESPIRATORY TRACT INFECTION FUNGAL |
2 |
0.0038 |
| 138 |
PERFORATION |
3 |
0.0037 |
| 139 |
EOSINOPHIL PERCENTAGE INCREASED |
2 |
0.0037 |
| 140 |
ENCEPHALOMYELITIS |
1 |
0.0037 |
| 141 |
LISTERIOSIS |
4 |
0.0036 |
| 142 |
FUNGAL SEPSIS |
3 |
0.0036 |
| 143 |
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION |
1 |
0.0036 |
| 144 |
RENAL CELL CARCINOMA STAGE UNSPECIFIED |
2 |
0.0035 |
| 145 |
LENS DISORDER |
1 |
0.0035 |
| 146 |
SUBCUTANEOUS NODULE |
1 |
0.0035 |
| 147 |
MEDIASTINITIS |
2 |
0.0034 |
| 148 |
CATHETER SITE HAEMATOMA |
1 |
0.0034 |
| 149 |
SERUM SICKNESS |
9 |
0.0032 |
| 150 |
HEPATOBILIARY DISEASE |
2 |
0.0032 |
| 151 |
ANOREXIA NERVOSA |
1 |
0.0031 |
| 152 |
GASTROENTERITIS BACTERIAL |
1 |
0.0030 |
| 153 |
AUTONOMIC NEUROPATHY |
3 |
0.0030 |
| 154 |
DRUG THERAPY |
1 |
0.0029 |
| 155 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 156 |
NEUTROPENIC COLITIS |
6 |
0.0029 |
| 157 |
MULTIPLE SYSTEM ATROPHY |
1 |
0.0028 |
| 158 |
FUNGAL OESOPHAGITIS |
2 |
0.0028 |
| 159 |
DERMATITIS DIAPER |
2 |
0.0028 |
| 160 |
MONOCYTE PERCENTAGE INCREASED |
2 |
0.0028 |
| 161 |
FAT EMBOLISM |
1 |
0.0028 |
| 162 |
DELAYED GRAFT FUNCTION |
2 |
0.0028 |
| 163 |
VASOGENIC CEREBRAL OEDEMA |
2 |
0.0028 |
| 164 |
HEMIANOPIA HOMONYMOUS |
2 |
0.0027 |
| 165 |
CHOROIDITIS |
1 |
0.0027 |
| 166 |
HEPATIC INFARCTION |
1 |
0.0027 |
| 167 |
LYMPHADENOPATHY MEDIASTINAL |
5 |
0.0026 |
| 168 |
NEPHROPATHY TOXIC |
29 |
0.0026 |
| 169 |
SYSTEMIC MYCOSIS |
3 |
0.0026 |
| 170 |
PULMONARY MYCOSIS |
2 |
0.0026 |
| 171 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
1 |
0.0025 |
| 172 |
MYOCARDIAL OEDEMA |
1 |
0.0025 |
| 173 |
EYE INFECTION TOXOPLASMAL |
1 |
0.0025 |
| 174 |
ELECTROMECHANICAL DISSOCIATION |
2 |
0.0025 |
| 175 |
VASCULAR ACCESS COMPLICATION |
2 |
0.0025 |
| 176 |
SPUTUM CULTURE POSITIVE |
2 |
0.0025 |
| 177 |
CEREBRAL ARTERY EMBOLISM |
3 |
0.0025 |
| 178 |
UREAPLASMA INFECTION |
1 |
0.0025 |
| 179 |
PAPILLOEDEMA |
11 |
0.0024 |
| 180 |
CSF PROTEIN INCREASED |
2 |
0.0024 |
| 181 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
3 |
0.0024 |
| 182 |
RETINITIS |
4 |
0.0023 |
| 183 |
LENTICULAR OPACITIES |
1 |
0.0023 |
| 184 |
ENTEROCOCCAL INFECTION |
11 |
0.0023 |
| 185 |
FACIAL NERVE DISORDER |
1 |
0.0023 |
| 186 |
MULTIPLE-DRUG RESISTANCE |
7 |
0.0023 |
| 187 |
MENINGITIS |
15 |
0.0022 |
| 188 |
TRANSPLANT DYSFUNCTION |
4 |
0.0022 |
| 189 |
PANCREATITIS HAEMORRHAGIC |
1 |
0.0022 |
| 190 |
EATING DISORDER SYMPTOM |
1 |
0.0022 |
| 191 |
MAGNESIUM DEFICIENCY |
1 |
0.0021 |
| 192 |
MENINGISM |
1 |
0.0021 |
| 193 |
METAPLASIA |
1 |
0.0021 |
| 194 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 195 |
MENINGITIS BACTERIAL |
3 |
0.0021 |
| 196 |
INTERCEPTED DRUG PRESCRIBING ERROR |
1 |
0.0020 |
| 197 |
BRAIN HERNIATION |
6 |
0.0020 |
| 198 |
PNEUMONIA PSEUDOMONAL |
3 |
0.0020 |
| 199 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
2 |
0.0019 |
| 200 |
POSTICTAL STATE |
2 |
0.0019 |
| 201 |
BRAIN OEDEMA |
24 |
0.0019 |
| 202 |
PULMONARY MUCORMYCOSIS |
1 |
0.0019 |
| 203 |
HUMAN POLYOMAVIRUS INFECTION |
1 |
0.0019 |
| 204 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 205 |
OSTEOMYELITIS ACUTE |
1 |
0.0018 |
| 206 |
HYDROCEPHALUS |
10 |
0.0018 |
| 207 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
7 |
0.0018 |
| 208 |
CLONUS |
5 |
0.0018 |
| 209 |
HAEMORRHAGIC INFARCTION |
1 |
0.0018 |
| 210 |
RETINOPATHY OF PREMATURITY |
1 |
0.0018 |
| 211 |
ISCHAEMIC STROKE |
32 |
0.0018 |
| 212 |
MENINGITIS TUBERCULOUS |
1 |
0.0018 |
| 213 |
INTRAVASCULAR HAEMOLYSIS |
1 |
0.0018 |
| 214 |
CEREBELLAR INFARCTION |
3 |
0.0018 |
| 215 |
METASTASES TO MENINGES |
4 |
0.0018 |
| 216 |
CEREBRAL VENTRICLE DILATATION |
2 |
0.0017 |
| 217 |
DRUG RESISTANCE |
44 |
0.0017 |
| 218 |
ASPERGILLUS INFECTION |
11 |
0.0017 |
| 219 |
ANTEROGRADE AMNESIA |
1 |
0.0017 |
| 220 |
BLOOD HIV RNA INCREASED |
3 |
0.0017 |
| 221 |
PARADOXICAL DRUG REACTION |
6 |
0.0016 |
| 222 |
STAPHYLOCOCCAL SKIN INFECTION |
2 |
0.0016 |
| 223 |
NEURODEGENERATIVE DISORDER |
1 |
0.0016 |
| 224 |
BLOOD BILIRUBIN DECREASED |
1 |
0.0016 |
| 225 |
BLOOD UREA DECREASED |
2 |
0.0016 |
| 226 |
HEPATOSPLENOMEGALY |
4 |
0.0016 |
| 227 |
BRONCHOPULMONARY ASPERGILLOSIS |
12 |
0.0015 |
| 228 |
CYTOMEGALOVIRUS CHORIORETINITIS |
3 |
0.0015 |
| 229 |
LUNG OPACITY |
4 |
0.0015 |
| 230 |
OESOPHAGEAL HAEMORRHAGE |
2 |
0.0015 |
| 231 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 232 |
BONE DEFORMITY |
1 |
0.0015 |
| 233 |
FUNGAL SKIN INFECTION |
6 |
0.0015 |
| 234 |
CARBON DIOXIDE INCREASED |
2 |
0.0015 |
| 235 |
CD4 LYMPHOCYTES DECREASED |
3 |
0.0014 |
| 236 |
CENTRAL NERVOUS SYSTEM LESION |
19 |
0.0014 |
| 237 |
B-CELL TYPE ACUTE LEUKAEMIA |
1 |
0.0014 |
| 238 |
CARDIOTOXICITY |
12 |
0.0013 |
| 239 |
MENINGITIS ASEPTIC |
6 |
0.0013 |
| 240 |
MULTIPLE DRUG THERAPY |
1 |
0.0013 |
| 241 |
PARAINFLUENZAE VIRUS INFECTION |
2 |
0.0013 |
| 242 |
NEUROLOGICAL DECOMPENSATION |
3 |
0.0013 |
| 243 |
BRAIN DEATH |
4 |
0.0013 |
| 244 |
RETINAL PIGMENTATION |
1 |
0.0013 |
| 245 |
PULMONARY VALVE STENOSIS |
1 |
0.0013 |
| 246 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
1 |
0.0013 |
| 247 |
CANDIDA INFECTION |
21 |
0.0012 |
| 248 |
CYSTITIS HAEMORRHAGIC |
5 |
0.0012 |
| 249 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 250 |
OPTIC ATROPHY |
2 |
0.0012 |
| 251 |
CEREBRAL INFARCTION |
30 |
0.0012 |
| 252 |
PULMONARY NOCARDIOSIS |
1 |
0.0012 |
| 253 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
4 |
0.0012 |
| 254 |
DRUG LEVEL INCREASED |
20 |
0.0012 |
| 255 |
SEPTIC EMBOLUS |
1 |
0.0012 |
| 256 |
JC VIRUS TEST POSITIVE |
1 |
0.0012 |
| 257 |
VITAL FUNCTIONS ABNORMAL |
1 |
0.0012 |
| 258 |
MILIARIA |
2 |
0.0012 |
| 259 |
TENSION HEADACHE |
5 |
0.0012 |
| 260 |
WOUND INFECTION STAPHYLOCOCCAL |
2 |
0.0012 |
| 261 |
GRANULOMA |
4 |
0.0012 |
| 262 |
PULMONARY CAVITATION |
1 |
0.0011 |
| 263 |
AXONAL NEUROPATHY |
1 |
0.0011 |
| 264 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 265 |
PROTEIN TOTAL INCREASED |
3 |
0.0011 |
| 266 |
CEREBRAL VENOUS THROMBOSIS |
2 |
0.0011 |
| 267 |
PNEUMONITIS |
30 |
0.0011 |
| 268 |
MUCOSAL EROSION |
1 |
0.0011 |
| 269 |
PNEUMONIA KLEBSIELLA |
2 |
0.0011 |
| 270 |
OTOTOXICITY |
2 |
0.0011 |
| 271 |
ACUTE PULMONARY OEDEMA |
6 |
0.0011 |
| 272 |
RENAL TUBULAR DISORDER |
3 |
0.0011 |
| 273 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
30 |
0.0011 |
| 274 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 275 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 276 |
LIP DISORDER |
2 |
0.0011 |
| 277 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 278 |
KIDNEY TRANSPLANT REJECTION |
5 |
0.0010 |
| 279 |
IDIOSYNCRATIC DRUG REACTION |
1 |
0.0010 |
| 280 |
PYELONEPHRITIS ACUTE |
2 |
0.0010 |
| 281 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
9 |
0.0010 |
| 282 |
BLOOD CULTURE POSITIVE |
3 |
0.0010 |
| 283 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0010 |
| 284 |
KLEBSIELLA INFECTION |
5 |
0.0010 |
| 285 |
GENOTYPE DRUG RESISTANCE TEST POSITIVE |
1 |
0.0010 |
| 286 |
TONGUE BITING |
2 |
0.0010 |
| 287 |
PARTIAL SEIZURES |
5 |
0.0010 |
| 288 |
LUNG ABSCESS |
2 |
0.0010 |
| 289 |
OEDEMA MUCOSAL |
1 |
0.0010 |
| 290 |
ELECTROLYTE IMBALANCE |
11 |
0.0009 |
| 291 |
ENTEROCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 292 |
FOETAL DISTRESS SYNDROME |
2 |
0.0009 |
| 293 |
RENAL IMPAIRMENT |
79 |
0.0009 |
| 294 |
PULMONARY MASS |
14 |
0.0009 |
| 295 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 296 |
INFECTION SUSCEPTIBILITY INCREASED |
2 |
0.0009 |
| 297 |
RIGHT VENTRICULAR DYSFUNCTION |
1 |
0.0009 |
| 298 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
2 |
0.0009 |
| 299 |
PSEUDOMEMBRANOUS COLITIS |
2 |
0.0009 |
| 300 |
CYTOGENETIC ABNORMALITY |
1 |
0.0009 |
| 301 |
DIABETIC RETINOPATHY |
3 |
0.0009 |
| 302 |
HYPERSENSITIVITY PNEUMONITIS |
1 |
0.0009 |
| 303 |
VITH NERVE PARALYSIS |
1 |
0.0009 |
| 304 |
CENTRAL NERVOUS SYSTEM INFECTION |
1 |
0.0009 |
| 305 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
47 |
0.0009 |
| 306 |
LIP ULCERATION |
1 |
0.0009 |
| 307 |
THROMBOPHLEBITIS |
3 |
0.0009 |
| 308 |
RECTAL ULCER |
1 |
0.0009 |
| 309 |
LYMPHOPENIA |
12 |
0.0008 |
| 310 |
BRADYKINESIA |
5 |
0.0008 |
| 311 |
INGROWING NAIL |
2 |
0.0008 |
| 312 |
PULMONARY INFARCTION |
2 |
0.0008 |
| 313 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 314 |
OXYGEN CONSUMPTION INCREASED |
2 |
0.0008 |
| 315 |
LACUNAR INFARCTION |
2 |
0.0008 |
| 316 |
ENDOPHTHALMITIS |
5 |
0.0008 |
| 317 |
HAEMATOLOGICAL INFECTION |
2 |
0.0008 |
| 318 |
HEART INJURY |
2 |
0.0008 |
| 319 |
AMPUTATION |
1 |
0.0008 |
| 320 |
CUTANEOUS T-CELL LYMPHOMA |
1 |
0.0008 |
| 321 |
WHITE MATTER LESION |
1 |
0.0008 |
| 322 |
PATHOGEN RESISTANCE |
7 |
0.0008 |
| 323 |
ASPERGILLOSIS |
1 |
0.0008 |
| 324 |
HYPOGAMMAGLOBULINAEMIA |
5 |
0.0008 |
| 325 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
2 |
0.0007 |
| 326 |
BEHAVIOUR DISORDER |
4 |
0.0007 |
| 327 |
IMMUNODEFICIENCY |
11 |
0.0007 |
| 328 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 329 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 330 |
CORNEAL OPACITY |
1 |
0.0007 |
| 331 |
MENINGITIS VIRAL |
1 |
0.0007 |
| 332 |
HYPERCALCAEMIA |
9 |
0.0007 |
| 333 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 334 |
VIRAEMIA |
1 |
0.0007 |
| 335 |
PERITONEAL HAEMORRHAGE |
1 |
0.0007 |
| 336 |
THROMBOTIC MICROANGIOPATHY |
7 |
0.0007 |
| 337 |
HYPOMAGNESAEMIA |
10 |
0.0007 |
| 338 |
HALLUCINATIONS, MIXED |
3 |
0.0007 |
| 339 |
PRERENAL FAILURE |
1 |
0.0007 |
| 340 |
NECK MASS |
2 |
0.0007 |
| 341 |
CHOLECYSTITIS ACUTE |
4 |
0.0007 |
| 342 |
PANCYTOPENIA |
39 |
0.0007 |
| 343 |
HALLUCINATION, AUDITORY |
11 |
0.0007 |
| 344 |
STRABISMUS |
2 |
0.0007 |
| 345 |
HEART VALVE REPLACEMENT |
1 |
0.0007 |
| 346 |
HISTIOCYTOSIS HAEMATOPHAGIC |
2 |
0.0007 |
| 347 |
HYPERTHERMIA MALIGNANT |
1 |
0.0007 |
| 348 |
METABOLIC ENCEPHALOPATHY |
2 |
0.0007 |
| 349 |
THYROIDITIS |
2 |
0.0007 |
| 350 |
HYPOAESTHESIA FACIAL |
1 |
0.0007 |
| 351 |
SUSPECTED OFF LABEL USE |
3 |
0.0007 |
| 352 |
CLOSTRIDIUM DIFFICILE COLITIS |
7 |
0.0007 |
| 353 |
FUNGAL PERITONITIS |
1 |
0.0007 |
| 354 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 355 |
MYOGLOBIN BLOOD INCREASED |
1 |
0.0007 |
| 356 |
CYTOPENIA |
8 |
0.0007 |
| 357 |
PALLIATIVE CARE |
1 |
0.0007 |
| 358 |
HYPOKALAEMIA |
30 |
0.0006 |
| 359 |
MYELITIS |
1 |
0.0006 |
| 360 |
BRONCHIAL DISORDER |
1 |
0.0006 |
| 361 |
HISTOPLASMOSIS DISSEMINATED |
1 |
0.0006 |
| 362 |
THERAPY NON-RESPONDER |
28 |
0.0006 |
| 363 |
DISINHIBITION |
1 |
0.0006 |
| 364 |
ANTICONVULSANT DRUG LEVEL INCREASED |
1 |
0.0006 |
| 365 |
BRADYPHRENIA |
4 |
0.0006 |
| 366 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
3 |
0.0006 |
| 367 |
OSTEOMYELITIS |
11 |
0.0006 |
| 368 |
SYSTEMIC INFECTION |
1 |
0.0006 |
| 369 |
CYTOMEGALOVIRUS INFECTION |
10 |
0.0006 |
| 370 |
VACCINATION FAILURE |
1 |
0.0006 |
| 371 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 372 |
BK VIRUS INFECTION |
2 |
0.0006 |
| 373 |
HEPATORENAL SYNDROME |
1 |
0.0006 |
| 374 |
ACUTE KIDNEY INJURY |
88 |
0.0006 |
| 375 |
SEPTIC SHOCK |
25 |
0.0006 |
| 376 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 377 |
HALLUCINATION, VISUAL |
12 |
0.0006 |
| 378 |
TYPE I HYPERSENSITIVITY |
2 |
0.0006 |
| 379 |
DISSEMINATED INTRAVASCULAR COAGULATION |
8 |
0.0006 |
| 380 |
LUNG INFILTRATION |
5 |
0.0006 |
| 381 |
FACIAL PARESIS |
2 |
0.0006 |
| 382 |
CARDIOGENIC SHOCK |
8 |
0.0006 |
| 383 |
LIVER TRANSPLANT REJECTION |
1 |
0.0006 |
| 384 |
SPONDYLITIS |
2 |
0.0005 |
| 385 |
DRUG LEVEL BELOW THERAPEUTIC |
3 |
0.0005 |
| 386 |
VIRAL MUTATION IDENTIFIED |
2 |
0.0005 |
| 387 |
AMYLASE INCREASED |
2 |
0.0005 |
| 388 |
VENTRICULAR FIBRILLATION |
6 |
0.0005 |
| 389 |
MENTAL STATUS CHANGES |
15 |
0.0005 |
| 390 |
GRANULOCYTE COUNT DECREASED |
1 |
0.0005 |
| 391 |
NECROSIS |
3 |
0.0005 |
| 392 |
LEUKOENCEPHALOPATHY |
2 |
0.0005 |
| 393 |
ANGIOPATHY |
3 |
0.0005 |
| 394 |
STATUS EPILEPTICUS |
6 |
0.0005 |
| 395 |
AUTOIMMUNE THYROIDITIS |
2 |
0.0005 |
| 396 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 397 |
AORTIC ANEURYSM |
4 |
0.0005 |
| 398 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 399 |
DRUG-INDUCED LIVER INJURY |
16 |
0.0005 |
| 400 |
PNEUMONIA FUNGAL |
2 |
0.0005 |
| 401 |
DIPLEGIA |
1 |
0.0005 |
| 402 |
GENE MUTATION |
1 |
0.0005 |
| 403 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 404 |
RESPIRATORY FAILURE |
36 |
0.0005 |
| 405 |
MUSCLE CONTRACTURE |
1 |
0.0005 |
| 406 |
ARTHRITIS BACTERIAL |
2 |
0.0005 |
| 407 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
5 |
0.0005 |
| 408 |
SOCIAL PROBLEM |
2 |
0.0005 |
| 409 |
MICROCYTIC ANAEMIA |
1 |
0.0005 |
| 410 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 411 |
SKIN PLAQUE |
4 |
0.0005 |
| 412 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 413 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 414 |
MULTI-ORGAN FAILURE |
8 |
0.0005 |
| 415 |
PRODUCT PRESCRIBING ISSUE |
10 |
0.0005 |
| 416 |
RENAL TUBULAR ACIDOSIS |
1 |
0.0005 |
| 417 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 418 |
MELANOCYTIC NAEVUS |
2 |
0.0005 |
| 419 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 420 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
2 |
0.0005 |
| 421 |
ABDOMINAL ABSCESS |
2 |
0.0005 |
| 422 |
BLOOD CREATINE INCREASED |
2 |
0.0005 |
| 423 |
CHOLESTATIC LIVER INJURY |
1 |
0.0004 |
| 424 |
ENCEPHALOPATHY |
11 |
0.0004 |
| 425 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 426 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 427 |
SHOCK |
10 |
0.0004 |
| 428 |
RENAL FAILURE |
57 |
0.0004 |
| 429 |
VITILIGO |
1 |
0.0004 |
| 430 |
VENTRICULAR TACHYCARDIA |
7 |
0.0004 |
| 431 |
PHOTOSENSITIVITY REACTION |
7 |
0.0004 |
| 432 |
URINARY TRACT OBSTRUCTION |
1 |
0.0004 |
| 433 |
CARDIAC TAMPONADE |
2 |
0.0004 |
| 434 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 435 |
VISUAL FIELD DEFECT |
3 |
0.0004 |
| 436 |
HEMIPARESIS |
7 |
0.0004 |
| 437 |
TREATMENT FAILURE |
34 |
0.0004 |
| 438 |
TRANSPLANT FAILURE |
1 |
0.0004 |
| 439 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 440 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 441 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
10 |
0.0004 |
| 442 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 443 |
HYPERAMMONAEMIA |
2 |
0.0004 |
| 444 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 445 |
DERMATITIS EXFOLIATIVE |
2 |
0.0004 |
| 446 |
BRAIN INJURY |
4 |
0.0004 |
| 447 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 448 |
TOXIC SKIN ERUPTION |
4 |
0.0004 |
| 449 |
PATHOLOGICAL FRACTURE |
2 |
0.0004 |
| 450 |
HAEMODYNAMIC INSTABILITY |
3 |
0.0004 |
| 451 |
SLUGGISHNESS |
4 |
0.0004 |
| 452 |
NOCARDIOSIS |
1 |
0.0004 |
| 453 |
ENDOCARDITIS |
2 |
0.0004 |
| 454 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 455 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
0.0004 |
| 456 |
SKIN ULCER |
10 |
0.0004 |
| 457 |
TORSADE DE POINTES |
3 |
0.0004 |
| 458 |
VIROLOGIC FAILURE |
2 |
0.0004 |
| 459 |
LIVER INJURY |
9 |
0.0004 |
| 460 |
DRUG INTERACTION |
58 |
0.0004 |
| 461 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 462 |
MACULE |
1 |
0.0004 |
| 463 |
FUNGAL INFECTION |
12 |
0.0004 |
| 464 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 465 |
PSYCHOMOTOR RETARDATION |
1 |
0.0004 |
| 466 |
DRUG INEFFECTIVE |
467 |
0.0004 |
| 467 |
NEUTROPENIA |
48 |
0.0004 |
| 468 |
PSEUDOMONAS INFECTION |
3 |
0.0003 |
| 469 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 470 |
HAEMOTHORAX |
1 |
0.0003 |
| 471 |
BONE MARROW FAILURE |
7 |
0.0003 |
| 472 |
VASCULITIS |
4 |
0.0003 |
| 473 |
STRIDOR |
1 |
0.0003 |
| 474 |
GROWTH RETARDATION |
1 |
0.0003 |
| 475 |
ELECTROCARDIOGRAM QT PROLONGED |
12 |
0.0003 |
| 476 |
HIV INFECTION |
1 |
0.0003 |
| 477 |
MYELOFIBROSIS |
1 |
0.0003 |
| 478 |
PNEUMONIA BACTERIAL |
3 |
0.0003 |
| 479 |
ISCHAEMIC CARDIOMYOPATHY |
1 |
0.0003 |
| 480 |
DEVICE RELATED INFECTION |
5 |
0.0003 |
| 481 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 482 |
OLIGURIA |
2 |
0.0003 |
| 483 |
SQUAMOUS CELL CARCINOMA |
3 |
0.0003 |
| 484 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 485 |
PHOTOPSIA |
2 |
0.0003 |
| 486 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 487 |
HEPATOTOXICITY |
7 |
0.0003 |
| 488 |
SUBSTANCE USE DISORDER |
1 |
0.0003 |
| 489 |
C-REACTIVE PROTEIN ABNORMAL |
2 |
0.0003 |
| 490 |
CARDIO-RESPIRATORY ARREST |
13 |
0.0003 |
| 491 |
ATELECTASIS |
3 |
0.0003 |
| 492 |
SKIN EROSION |
1 |
0.0003 |
| 493 |
HERPES SIMPLEX |
2 |
0.0003 |
| 494 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 495 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 496 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
3 |
0.0003 |
| 497 |
BLOOD CREATININE INCREASED |
19 |
0.0003 |
| 498 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 499 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
6 |
0.0003 |
| 500 |
MALNUTRITION |
3 |
0.0003 |
| 501 |
IMPULSIVE BEHAVIOUR |
1 |
0.0003 |
| 502 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 503 |
DISEASE PROGRESSION |
31 |
0.0003 |
| 504 |
LIPASE INCREASED |
2 |
0.0003 |
| 505 |
ACUTE RESPIRATORY FAILURE |
5 |
0.0003 |
| 506 |
COGNITIVE DISORDER |
12 |
0.0003 |
| 507 |
PROSTATOMEGALY |
1 |
0.0003 |
| 508 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 509 |
PREMATURE DELIVERY |
4 |
0.0003 |
| 510 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 511 |
AZOTAEMIA |
1 |
0.0003 |
| 512 |
CONDITION AGGRAVATED |
76 |
0.0002 |
| 513 |
CANDIDIASIS |
1 |
0.0002 |
| 514 |
HYPONATRAEMIA |
14 |
0.0002 |
| 515 |
SENSORY LOSS |
2 |
0.0002 |
| 516 |
ORGAN FAILURE |
1 |
0.0002 |
| 517 |
RHINITIS |
2 |
0.0002 |
| 518 |
RECURRENT CANCER |
1 |
0.0002 |
| 519 |
EMBOLISM |
2 |
0.0002 |
| 520 |
HEMIPLEGIA |
2 |
0.0002 |
| 521 |
LUNG NEOPLASM |
1 |
0.0002 |
| 522 |
ANAPHYLACTIC SHOCK |
6 |
0.0002 |
| 523 |
ANURIA |
2 |
0.0002 |
| 524 |
HEPATIC LESION |
1 |
0.0002 |
| 525 |
IMMUNOSUPPRESSION |
2 |
0.0002 |
| 526 |
TOXICITY TO VARIOUS AGENTS |
38 |
0.0002 |
| 527 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 528 |
TACHYPNOEA |
3 |
0.0002 |
| 529 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 530 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 531 |
ISCHAEMIA |
1 |
0.0002 |
| 532 |
RESPIRATORY DISTRESS |
6 |
0.0002 |
| 533 |
GRAND MAL CONVULSION |
2 |
0.0002 |
| 534 |
PERICARDIAL EFFUSION |
5 |
0.0002 |
| 535 |
MASS |
3 |
0.0002 |
| 536 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 537 |
DIALYSIS |
3 |
0.0002 |
| 538 |
COLITIS |
8 |
0.0002 |
| 539 |
CARDIAC ARREST |
17 |
0.0002 |
| 540 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 541 |
HYPOTONIA |
2 |
0.0002 |
| 542 |
HEPATIC FAILURE |
6 |
0.0002 |
| 543 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 544 |
CACHEXIA |
1 |
0.0002 |
| 545 |
MYELOSUPPRESSION |
7 |
0.0002 |
| 546 |
SKIN NECROSIS |
1 |
0.0002 |
| 547 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 548 |
C-REACTIVE PROTEIN INCREASED |
7 |
0.0002 |
| 549 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 550 |
DERMATITIS |
4 |
0.0002 |
| 551 |
FOLLICULITIS |
2 |
0.0002 |
| 552 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 553 |
DRUG INTOLERANCE |
18 |
0.0002 |
| 554 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
0.0002 |
| 555 |
SKIN LESION |
5 |
0.0002 |
| 556 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 557 |
GENERALISED TONIC-CLONIC SEIZURE |
3 |
0.0002 |
| 558 |
PLEURAL EFFUSION |
11 |
0.0002 |
| 559 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 560 |
PANCREATITIS ACUTE |
4 |
0.0002 |
| 561 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 562 |
GRANULOCYTOPENIA |
1 |
0.0002 |
| 563 |
EOSINOPHILIA |
3 |
0.0002 |
| 564 |
SPLENOMEGALY |
2 |
0.0002 |
| 565 |
HYPOXIA |
6 |
0.0002 |
| 566 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 567 |
PSYCHOTIC DISORDER |
5 |
0.0002 |
| 568 |
DRUG ERUPTION |
3 |
0.0002 |
| 569 |
BACTERAEMIA |
2 |
0.0002 |
| 570 |
PLEURISY |
1 |
0.0002 |
| 571 |
COMA |
8 |
0.0002 |
| 572 |
RHABDOMYOLYSIS |
7 |
0.0002 |
| 573 |
PYREXIA |
58 |
0.0002 |
| 574 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 575 |
RENAL FAILURE ACUTE |
7 |
0.0002 |
| 576 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 577 |
TREATMENT NONCOMPLIANCE |
9 |
0.0002 |
| 578 |
MUSCLE SPASTICITY |
2 |
0.0002 |
| 579 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 580 |
ILEUS |
2 |
0.0002 |
| 581 |
HEPATIC FUNCTION ABNORMAL |
6 |
0.0002 |
| 582 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 583 |
OFF LABEL USE |
140 |
0.0002 |
| 584 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 585 |
HYPOPHAGIA |
4 |
0.0002 |
| 586 |
METABOLIC ACIDOSIS |
5 |
0.0002 |
| 587 |
HEPATITIS |
4 |
0.0002 |
| 588 |
ENTERITIS |
1 |
0.0002 |
| 589 |
MUCOSAL INFLAMMATION |
4 |
0.0002 |
| 590 |
THROMBOCYTOPENIA |
17 |
0.0002 |
| 591 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 592 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 593 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 594 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 595 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 596 |
UVEITIS |
2 |
0.0001 |
| 597 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 598 |
DRUG TOXICITY |
2 |
0.0001 |
| 599 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 600 |
INFARCTION |
1 |
0.0001 |
| 601 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 602 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 603 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 604 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 605 |
METASTASIS |
1 |
0.0001 |
| 606 |
NEUTROPENIC SEPSIS |
1 |
0.0001 |
| 607 |
LEUKOPENIA |
7 |
0.0001 |
| 608 |
CONVULSION |
8 |
0.0001 |
| 609 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
4 |
0.0001 |
| 610 |
LIVER FUNCTION TEST ABNORMAL |
4 |
0.0001 |
| 611 |
RASH PUSTULAR |
1 |
0.0001 |
| 612 |
GASTROENTERITIS |
2 |
0.0001 |
| 613 |
ASCITES |
4 |
0.0001 |
| 614 |
INFLAMMATION |
7 |
0.0001 |
| 615 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 616 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 617 |
STEVENS-JOHNSON SYNDROME |
3 |
0.0001 |
| 618 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 619 |
SEPSIS |
15 |
0.0001 |
| 620 |
RASH PAPULAR |
3 |
0.0001 |
| 621 |
ATRIAL FIBRILLATION |
13 |
0.0001 |
| 622 |
HEPATIC ENZYME INCREASED |
9 |
0.0001 |
| 623 |
OSTEOPENIA |
2 |
0.0001 |
| 624 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 625 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 626 |
HYPERTHERMIA |
1 |
0.0001 |
| 627 |
EPILEPSY |
4 |
0.0001 |
| 628 |
ACIDOSIS |
1 |
0.0001 |
| 629 |
ALANINE AMINOTRANSFERASE INCREASED |
8 |
0.0001 |
| 630 |
LUNG INFECTION |
2 |
0.0001 |
| 631 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 632 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 633 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 634 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
5 |
0.0001 |
| 635 |
ABNORMAL BEHAVIOUR |
5 |
0.0001 |
| 636 |
PNEUMOTHORAX |
2 |
0.0001 |
| 637 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 638 |
RENAL CYST |
1 |
0.0001 |
| 639 |
LOW BIRTH WEIGHT BABY |
1 |
0.0001 |
| 640 |
ABSCESS |
2 |
0.0001 |
| 641 |
TRANSPLANT REJECTION |
1 |
0.0001 |
| 642 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 643 |
EYE DISORDER |
4 |
0.0001 |
| 644 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 645 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 646 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 647 |
COAGULOPATHY |
2 |
0.0001 |
| 648 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 649 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 650 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 651 |
MYOPATHY |
1 |
0.0001 |
| 652 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 653 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
8 |
0.0001 |
| 654 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 655 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 656 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 657 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 658 |
FLANK PAIN |
1 |
0.0001 |
| 659 |
PHOTOPHOBIA |
2 |
0.0001 |
| 660 |
ABORTION INDUCED |
1 |
0.0001 |
| 661 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 662 |
ANAEMIA |
20 |
0.0001 |
| 663 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 664 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 665 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 666 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 667 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 668 |
RENAL INJURY |
3 |
0.0001 |
| 669 |
GASTROINTESTINAL DISORDER |
9 |
0.0001 |
| 670 |
VOMITING |
47 |
0.0001 |
| 671 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 672 |
PREMATURE BABY |
3 |
0.0001 |
| 673 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 674 |
CONFUSIONAL STATE |
16 |
0.0001 |
| 675 |
HYPOTHERMIA |
1 |
0.0001 |
| 676 |
FEEDING DISORDER |
2 |
0.0001 |
| 677 |
EYELID PTOSIS |
1 |
0.0001 |
| 678 |
BLINDNESS |
4 |
0.0001 |
| 679 |
SKELETAL INJURY |
1 |
0.0001 |
| 680 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 681 |
PETECHIAE |
1 |
0.0001 |
| 682 |
JOINT DISLOCATION |
1 |
0.0001 |
| 683 |
NIGHT SWEATS |
3 |
0.0001 |
| 684 |
HEADACHE |
58 |
0.0001 |
| 685 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 686 |
MENTAL DISORDER |
4 |
0.0001 |
| 687 |
WOUND INFECTION |
1 |
0.0001 |
| 688 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 689 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 690 |
MEDICATION ERROR |
5 |
0.0001 |
| 691 |
PRODUCT USE IN UNAPPROVED INDICATION |
22 |
0.0001 |
| 692 |
REBOUND EFFECT |
1 |
0.0001 |
| 693 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 694 |
PNEUMONIA |
28 |
0.0001 |
| 695 |
DELIRIUM |
3 |
0.0001 |
| 696 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 697 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 698 |
DYSPHAGIA |
8 |
0.0001 |
| 699 |
ATAXIA |
1 |
0.0001 |
| 700 |
THERAPEUTIC RESPONSE DECREASED |
5 |
0.0001 |
| 701 |
ACCIDENTAL OVERDOSE |
3 |
0.0001 |
| 702 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 703 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 704 |
CARDIOMEGALY |
1 |
0.0001 |
| 705 |
CYST |
1 |
0.0001 |
| 706 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 707 |
MATERNAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 708 |
SEIZURE |
9 |
0.0001 |
| 709 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 710 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 711 |
NODULE |
1 |
0.0001 |
| 712 |
ANHEDONIA |
2 |
0.0001 |
| 713 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 714 |
DEPRESSED MOOD |
4 |
0.0001 |
| 715 |
NEUTROPHIL COUNT DECREASED |
3 |
0.0001 |
| 716 |
OSTEOPOROSIS |
3 |
0.0001 |
| 717 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 718 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 719 |
BRONCHOSPASM |
1 |
0.0001 |
| 720 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 721 |
INFECTION |
10 |
0.0001 |
| 722 |
DECREASED APPETITE |
16 |
0.0001 |
| 723 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 724 |
DYSGEUSIA |
5 |
0.0001 |
| 725 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 726 |
APHASIA |
2 |
0.0001 |
| 727 |
INSURANCE ISSUE |
1 |
0.0001 |
| 728 |
LYMPHOMA |
1 |
0.0001 |
| 729 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 730 |
DELUSION |
1 |
0.0001 |
| 731 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 732 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 733 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 734 |
ARRHYTHMIA |
3 |
0.0001 |
| 735 |
PULMONARY EMBOLISM |
6 |
0.0001 |
| 736 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 737 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 738 |
CARDIAC FAILURE |
5 |
0.0001 |
| 739 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 740 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 741 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 742 |
URINARY TRACT INFECTION |
10 |
0.0001 |
| 743 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 744 |
HYPERKALAEMIA |
2 |
0.0001 |
| 745 |
NAUSEA |
45 |
0.0001 |
| 746 |
PANCREATITIS |
3 |
0.0001 |
| 747 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 748 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 749 |
PLATELET COUNT DECREASED |
6 |
0.0001 |
| 750 |
TACHYCARDIA |
5 |
0.0001 |
| 751 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 752 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 753 |
HYPOTENSION |
11 |
0.0001 |
| 754 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 755 |
THINKING ABNORMAL |
1 |
0.0001 |
| 756 |
BLISTER |
3 |
0.0001 |
| 757 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 758 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 759 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 760 |
GASTRIC ULCER |
1 |
0.0001 |
| 761 |
LETHARGY |
3 |
0.0001 |
| 762 |
CHOLESTASIS |
1 |
0.0001 |
| 763 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 764 |
ABDOMINAL PAIN |
12 |
0.0001 |
| 765 |
EAR PAIN |
1 |
0.0001 |
| 766 |
DIARRHOEA |
33 |
0.0001 |
| 767 |
KIDNEY INFECTION |
1 |
0.0001 |
| 768 |
PREGNANCY |
1 |
0.0000 |
| 769 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 770 |
CHEST PAIN |
9 |
0.0000 |
| 771 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 772 |
DRUG ABUSE |
4 |
0.0000 |
| 773 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 774 |
RETCHING |
1 |
0.0000 |
| 775 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 776 |
LIVER DISORDER |
2 |
0.0000 |
| 777 |
PARAESTHESIA |
7 |
0.0000 |
| 778 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 779 |
RENAL DISORDER |
2 |
0.0000 |
| 780 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 781 |
PRURITUS |
16 |
0.0000 |
| 782 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 783 |
LUNG DISORDER |
2 |
0.0000 |
| 784 |
CELLULITIS |
2 |
0.0000 |
| 785 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 786 |
THERAPY CESSATION |
2 |
0.0000 |
| 787 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 788 |
DIPLOPIA |
1 |
0.0000 |
| 789 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 790 |
SPEECH DISORDER |
2 |
0.0000 |
| 791 |
FEAR |
1 |
0.0000 |
| 792 |
JAUNDICE |
1 |
0.0000 |
| 793 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 794 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 795 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 796 |
HAEMOPTYSIS |
1 |
0.0000 |
| 797 |
DEMENTIA |
1 |
0.0000 |
| 798 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 799 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 800 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 801 |
DEATH |
30 |
0.0000 |
| 802 |
HERPES ZOSTER |
2 |
0.0000 |
| 803 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 804 |
NASAL CONGESTION |
2 |
0.0000 |
| 805 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 806 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 807 |
CATARACT |
2 |
0.0000 |
| 808 |
HYPOAESTHESIA |
5 |
0.0000 |
| 809 |
NO ADVERSE EVENT |
6 |
0.0000 |
| 810 |
HYPERTENSION |
7 |
0.0000 |
| 811 |
SWELLING |
3 |
0.0000 |
| 812 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 813 |
HIP FRACTURE |
1 |
0.0000 |
| 814 |
PAIN IN EXTREMITY |
9 |
0.0000 |
| 815 |
HEART RATE INCREASED |
3 |
0.0000 |
| 816 |
VIRAL INFECTION |
1 |
0.0000 |
| 817 |
SOMNOLENCE |
6 |
0.0000 |
| 818 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 819 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 820 |
VISION BLURRED |
4 |
0.0000 |
| 821 |
HAEMORRHAGE |
3 |
0.0000 |
| 822 |
COVID-19 |
5 |
0.0000 |
| 823 |
HEART RATE DECREASED |
1 |
0.0000 |
| 824 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 825 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 826 |
AGITATION |
2 |
0.0000 |
| 827 |
FALL |
9 |
0.0000 |
| 828 |
DYSARTHRIA |
1 |
0.0000 |
| 829 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 830 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 831 |
DIABETES MELLITUS |
2 |
0.0000 |
| 832 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 833 |
HOSPITALISATION |
4 |
0.0000 |
| 834 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 835 |
CHILLS |
3 |
0.0000 |
| 836 |
DISORIENTATION |
1 |
0.0000 |
| 837 |
RASH |
11 |
0.0000 |
| 838 |
WEIGHT DECREASED |
7 |
0.0000 |
| 839 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 840 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 841 |
DYSKINESIA |
1 |
0.0000 |
| 842 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 843 |
HYPOACUSIS |
1 |
0.0000 |
| 844 |
OVERDOSE |
5 |
0.0000 |
| 845 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 846 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 847 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 848 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 849 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 850 |
TINNITUS |
1 |
0.0000 |
| 851 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 852 |
BACK PAIN |
5 |
0.0000 |
| 853 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 854 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 855 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 856 |
ALOPECIA |
4 |
0.0000 |
| 857 |
DRY EYE |
1 |
0.0000 |
| 858 |
SINUSITIS |
2 |
0.0000 |
| 859 |
ERYTHEMA |
4 |
0.0000 |
| 860 |
BRADYCARDIA |
1 |
0.0000 |
| 861 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 862 |
OEDEMA |
1 |
0.0000 |
| 863 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 864 |
DIZZINESS |
9 |
0.0000 |
| 865 |
EYE PAIN |
1 |
0.0000 |
| 866 |
ANXIETY |
5 |
0.0000 |
| 867 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 868 |
BONE PAIN |
1 |
0.0000 |
| 869 |
SURGERY |
1 |
0.0000 |
| 870 |
WHEEZING |
1 |
0.0000 |
| 871 |
JOINT SWELLING |
2 |
0.0000 |
| 872 |
STOMATITIS |
1 |
0.0000 |
| 873 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 874 |
VERTIGO |
1 |
0.0000 |
| 875 |
DISCOMFORT |
1 |
0.0000 |
| 876 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 877 |
ASTHENIA |
6 |
0.0000 |
| 878 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 879 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 880 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 881 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 882 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 883 |
COUGH |
4 |
0.0000 |
| 884 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 885 |
INJURY |
1 |
0.0000 |
| 886 |
DYSPNOEA |
8 |
0.0000 |
| 887 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 888 |
UNDERDOSE |
1 |
0.0000 |
| 889 |
EPISTAXIS |
1 |
0.0000 |
| 890 |
HALLUCINATION |
1 |
0.0000 |
| 891 |
HOT FLUSH |
1 |
0.0000 |
| 892 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 893 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 894 |
DRY MOUTH |
1 |
0.0000 |
| 895 |
TREMOR |
2 |
0.0000 |
| 896 |
ARTHRALGIA |
5 |
0.0000 |
| 897 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 898 |
BALANCE DISORDER |
1 |
0.0000 |
| 899 |
FATIGUE |
9 |
0.0000 |
| 900 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 901 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 902 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 903 |
MIGRAINE |
1 |
0.0000 |
| 904 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 905 |
SYNCOPE |
1 |
0.0000 |
| 906 |
FLUSHING |
1 |
0.0000 |
| 907 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 908 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 909 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 910 |
MALAISE |
4 |
0.0000 |
| 911 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 912 |
HYPERHIDROSIS |
1 |
0.0000 |
| 913 |
PSORIASIS |
1 |
0.0000 |
| 914 |
DEHYDRATION |
1 |
0.0000 |
| 915 |
DRY SKIN |
1 |
0.0000 |
| 916 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 917 |
PAIN |
4 |
0.0000 |
| 918 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 919 |
URTICARIA |
1 |
0.0000 |
| 920 |
MYALGIA |
1 |
0.0000 |
| 921 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 922 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 923 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 924 |
CONSTIPATION |
1 |
0.0000 |
| 925 |
DEPRESSION |
1 |
0.0000 |
| 926 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |